Warts Therapeutics Market Developments and Forecast by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Warts Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Common Warts, Genital Warts, Flat Warts, and Others), Treatment (Physical Destruction, Immunomodulation, and Chemical Destruction), and End User (Hospitals, Homecare, Specialty Clinics, and Others)

  • Report Date : Aug 2021
  • Report Code : TIPRE00024332
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 401

The warts therapeutics market was valued US$ 1,829.54 million in 2021, it is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

The growth of the warts therapeutics market is attributed to rising prevalence of human papillomavirus infections and recurrence of genital warts, and development of new products. However, poor diagnostics scenario in low-income countries restrains the market growth. Warts are skin growth caused by the human papillomaviruses (HPV). There are more than 60 types of HPVs, and several of these tend to cause warts on the skin. Although topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects, they may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60–90% and less than 10–20% recurrence rate.

In the US, the demand for warts treatment procedures has reduced due to the shift in focus on COVID-19. The pandemic has been causing havoc in the global supply chains, consumer markets, and economies as a whole. As a result of the measures implemented by governments around the world have negatively impacted the warts therapeutics market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Warts Therapeutics Market: Strategic Insights

warts-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights


Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts Fuel Warts Therapeutics Market Growth


Warts are caused by various strains of human papillomaviruses (HPV), and different strains cause warts in different parts of the body. Healthy persons coming in contact with warts can acquire the infection. As per the Centers for Disease Control and Prevention (CDC), in 2018, ~20% of the population, i.e., ~42.5 million people, in the US had sexually transmitted infections (STIs). In addition, before HPV vaccination, genital warts affected ~340,000–360,000 women and men in the US annually. Moreover, the recurrence rate for genital warts is high. As per the National Center for Biotechnology Information (NCBI), ~30% of total warts cases globally are expected to regress within the first four months of infection. In addition, HPV infections lead to cervical cancer, and cervical cancer is the fourth most common cancer among women globally. As per the World Health Organization (WHO), ~570,000 new cases of cervical cancer recorded in 2018 with high prevalence in low-income countries. Hence, an increase in the prevalence of HPV infections, leading to a rise in wart cases, and the high recurrence rate of warts are driving the wart therapeutics market growth.

Type-Based Insights


Based on type, the warts therapeutics market is further segmented into common warts, genital warts, flat warts, and others. The common warts segment holds the largest share of the market. However, the genital warts segment is anticipated to register the highest CAGR during 2021–2028. Genital warts refer to sexually transmitted infection that are usually caused due to HPV. The increasing prevalence of STDs and growing research and development efforts to develop genital warts treatment options would propel the market growth of this segment in the coming years.

Treatment - Based Insights


Based on treatment, the warts therapeutics market is further segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. The immunomodulation is sub segmented into interferons, retinoids, and zinc. The chemical destruction segment is further divided into bleomycin, cantharidin, salicylic acid, and others. The physical destruction segment holds the largest share of the warts therapeutics market and is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights


Based on end user, the warts therapeutics market is segmented into hospitals, homecare, specialty clinics, and others. The hospitals segment holds the largest market share. However, the homecare segment is estimated to register the highest CAGR during the forecast period. The projected market growth for this segment can be attributed to the increasing number of hospitals across the world, and rapidly growing number of surgical procedures.
         
Companies operating in the warts therapeutics market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Warts Therapeutics Market Regional Insights

The regional trends and factors influencing the Warts Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Warts Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

warts-market-global-geography
  • Get the Regional Specific Data for Warts Therapeutics Market

Warts Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.83 Billion
Market Size by 2028 US$ 2.31 Billion
Global CAGR (2021 - 2028) 3.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Common Warts
  • Genital Warts
  • Flat Warts
By Treatment
  • Physical Destruction
  • Immunomodulation
  • Chemical Destruction
By End User
  • Hospitals
  • Homecare
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bausch Health Companies Inc.
  • Nielsen BioSciences, Inc.
  • Euro Vital Pharma GmbH
  • Cipla Inc.
  • Koninklijke Utermöhlen NV
  • Novan, Inc.
  • Scholl's Wellness Company
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Verrica Pharmaceuticals Inc.

  • Warts Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

    The Warts Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Warts Therapeutics Market are:

    1. Bausch Health Companies Inc.
    2. Nielsen BioSciences, Inc.
    3. Euro Vital Pharma GmbH
    4. Cipla Inc.
    5. Koninklijke Utermöhlen NV

    Disclaimer: The companies listed above are not ranked in any particular order.


    warts-market-cagr

    • Get the Warts Therapeutics Market top key players overview

    Warts Therapeutics Market – by Type

    • Common Warts
    • Genital Warts
    • Flat Warts
    • Others

    Warts Therapeutics Market – by Treatment

    • Physical Destruction 
      • Cryotherapy
      • Surgical Removal
      • Laser Treatment
    • Immunomodulation
      • Interferons
      • Retinoids
      • Zinc
    • Chemical Destruction
      • Bleomycin
      • Cantharidin
      • Salicylic Acid
      • Others

    Warts Therapeutics Market – by End User

    • Hospitals
    • Homecare
    • Specialty Clinics
    • Others

    Warts Therapeutics Market– by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Bausch Health Companies Inc.      
    • Nielsen BioSciences, Inc.    
    • Euro Vital Pharma GmbH    
    • Cipla Inc.     
    • Koninklijke Utermöhlen NV           
    • Novan, Inc.            
    • Scholl's Wellness Company           
    • TEVA PHARMACEUTICAL INDUSTRIES LTD          
    • Verrica Pharmaceuticals Inc.        
    • GlaxoSmithKline plc.          
    • AIM ImmunoTech Inc

    Frequently Asked Questions

    Which segment is growing at the highest CAGR in the Warts Therapeutics market?

    The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.

    Which region is the fastest growing in the Warts Therapeutics market?

    Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.

    Which region is dominated the warts therapeutics market?

    North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

    Who are the developments carrying out by major players in the warts therapeutics market?

    Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

    What are the driving factors for the Warts Therapeutics market across the globe?

    The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.

    What are warts therapeutics?

    Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Warts Therapeutics Market

    1. Bausch Health Companies Inc.            
    2. Nielsen BioSciences, Inc.        
    3. Euro Vital Pharma GmbH        
    4. Cipla Inc.       
    5. Koninklijke Utermöhlen NV      
    6. Novan, Inc.    
    7. Scholl's Wellness Company    
    8. TEVA PHARMACEUTICAL INDUSTRIES LTD               
    9. Verrica Pharmaceuticals Inc.    
    10. GlaxoSmithKline plc.              
    11. AIM ImmunoTech Inc
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo